Declining CD4 count


image_pdfimage_print

Declining CD4 count

CD4 Counts vs months on HAART

In this series of graphics we describe how the initiation of antiretroviral therapy with a regimen containing, in part, Didanosine (ddI) and Tenofovir (TDF) results first in immune re-constitution and viraemic control. Then after a short time how this is followed by a decline in the CD4+ T cell count despite the adequate control of viraemia. Finally how the CD4+ count recovers and is rectified by a change in drug regimen revealing an underlying drug toxicity effect on CD4+ T cell proliferation.

The graphics further depict how ddI and TDF are metabolised and interact to ultimately cause impairment of DNA synthesis and cell apoptosis following mitochondrial toxicity.

Associated Case Study – Declining CD4 count, despite viral suppression?

Download Declining CD4 Count Guide

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineScience Education PrizesElizabeth Glazer Pediatric Aids FoundationAlere